vs
Apyx Medical Corp（APYX）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是Apyx Medical Corp的1.4倍（$25.9M vs $19.2M），REDWOOD TRUST INC净利率更高（77.2% vs -6.8%，领先84.0%），Apyx Medical Corp同比增速更快（34.7% vs -6.1%），过去两年Apyx Medical Corp的营收复合增速更高（36.8% vs -41.0%）
Apyx Medical前身是博维医疗，是美国的医疗器械制造商，专注生产电外科产品与能源技术相关医疗设备，公司总部位于佛罗里达州克利尔沃特，在保加利亚设有生产工厂。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
APYX vs RWT — 直观对比
营收规模更大
RWT
是对方的1.4倍
$19.2M
营收增速更快
APYX
高出40.8%
-6.1%
净利率更高
RWT
高出84.0%
-6.8%
两年增速更快
APYX
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $25.9M |
| 净利润 | $-1.3M | $20.0M |
| 毛利率 | 62.6% | — |
| 营业利润率 | 0.1% | — |
| 净利率 | -6.8% | 77.2% |
| 营收同比 | 34.7% | -6.1% |
| 净利润同比 | 71.9% | 402.6% |
| 每股收益（稀释后） | — | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APYXRWT
| Q4 25 | $19.2M | $25.9M | ||
| Q3 25 | $12.9M | $15.0M | ||
| Q2 25 | $11.4M | $13.8M | ||
| Q1 25 | $9.4M | $27.9M | ||
| Q4 24 | $14.2M | $27.6M | ||
| Q3 24 | $11.5M | $25.5M | ||
| Q2 24 | $12.1M | $67.4M | ||
| Q1 24 | $10.2M | $74.5M |
净利润APYXRWT
| Q4 25 | $-1.3M | $20.0M | ||
| Q3 25 | $-2.0M | $-7.7M | ||
| Q2 25 | $-3.8M | $-98.5M | ||
| Q1 25 | $-4.2M | $16.1M | ||
| Q4 24 | $-4.6M | $-6.6M | ||
| Q3 24 | $-4.7M | $14.8M | ||
| Q2 24 | $-6.6M | $15.5M | ||
| Q1 24 | $-7.6M | $30.3M |
毛利率APYXRWT
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
营业利润率APYXRWT
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | -9.0% | ||
| Q2 25 | -22.6% | -679.0% | ||
| Q1 25 | -32.4% | 80.2% | ||
| Q4 24 | -21.4% | -1.3% | ||
| Q3 24 | -31.6% | 86.1% | ||
| Q2 24 | -45.7% | 30.3% | ||
| Q1 24 | -64.6% | 41.3% |
净利率APYXRWT
| Q4 25 | -6.8% | 77.2% | ||
| Q3 25 | -15.4% | -51.4% | ||
| Q2 25 | -33.2% | -712.0% | ||
| Q1 25 | -44.0% | 57.8% | ||
| Q4 24 | -32.5% | -24.0% | ||
| Q3 24 | -40.9% | 58.1% | ||
| Q2 24 | -54.0% | 23.0% | ||
| Q1 24 | -74.0% | 40.6% |
每股收益（稀释后）APYXRWT
| Q4 25 | — | $0.11 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.76 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | — | $0.09 | ||
| Q2 24 | $-0.19 | $0.10 | ||
| Q1 24 | $-0.22 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $255.7M |
| 总债务越低越好 | $37.5M | — |
| 股东权益账面价值 | $14.5M | $982.6M |
| 总资产 | $66.8M | $23.7B |
| 负债/权益比越低杠杆越低 | 2.58× | — |
8季度趋势，按日历期对齐
现金及短期投资APYXRWT
| Q4 25 | $31.7M | $255.7M | ||
| Q3 25 | $25.1M | $226.3M | ||
| Q2 25 | $29.3M | $302.0M | ||
| Q1 25 | $31.0M | $259.9M | ||
| Q4 24 | $31.7M | $245.2M | ||
| Q3 24 | $28.0M | $253.7M | ||
| Q2 24 | $32.7M | $275.6M | ||
| Q1 24 | $37.3M | $275.4M |
总债务APYXRWT
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益APYXRWT
| Q4 25 | $14.5M | $982.6M | ||
| Q3 25 | $5.8M | $999.0M | ||
| Q2 25 | $7.3M | $1.1B | ||
| Q1 25 | $10.5M | $1.2B | ||
| Q4 24 | $14.2M | $1.2B | ||
| Q3 24 | $11.0M | $1.2B | ||
| Q2 24 | $14.7M | $1.2B | ||
| Q1 24 | $20.3M | $1.2B |
总资产APYXRWT
| Q4 25 | $66.8M | $23.7B | ||
| Q3 25 | $57.4M | $22.6B | ||
| Q2 25 | $58.2M | $21.3B | ||
| Q1 25 | $60.2M | $19.9B | ||
| Q4 24 | $64.8M | $18.3B | ||
| Q3 24 | $60.7M | $18.4B | ||
| Q2 24 | $65.4M | $16.5B | ||
| Q1 24 | $70.7M | $15.1B |
负债/权益比APYXRWT
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | — |
| 自由现金流率自由现金流/营收 | -14.6% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-9.1M | — |
8季度趋势，按日历期对齐
经营现金流APYXRWT
| Q4 25 | $-2.5M | $-10.1B | ||
| Q3 25 | $-3.5M | $-2.7B | ||
| Q2 25 | $-1.2M | $-2.1B | ||
| Q1 25 | $-702.0K | $-2.0B | ||
| Q4 24 | $-2.9M | $-5.9B | ||
| Q3 24 | $-4.4M | $-2.1B | ||
| Q2 24 | $-4.3M | $-2.0B | ||
| Q1 24 | $-6.3M | $-954.2M |
自由现金流APYXRWT
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
自由现金流率APYXRWT
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
资本支出强度APYXRWT
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
现金转化率APYXRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
